Since the advent of hybridoma technology more than two decades ago, numerous antibodies have entered the clinical setting as potent therapeutic agents. Their repeated application in humans, however, is limited by the development of human antimouse antibodies (HAMA) in the recipient, leading to allergic re- tions against the foreign murine protein and rapid neutralization. To circumvent these limitations many new antibodies have recently been tailored through recombinant antibody technology. The initial clinical data show encouraging results, thus demonstrating the potential of these new...

Studienarbeit aus dem Jahr 2005 im Fachbereich Medien / Kommunikation - Multimedia, Internet, neue Technologien, Note: 1, Hochschule Ansbach - Hochschule fur angewandte Wissenschaften Fachhochschule Ansbach, 10 Quellen im Literaturverzeichnis, Sprache: Deutsch, Abstract: Seit Alexander Graham Bell die erste PSTN-Verbindung herstellte, hat sich im Bereich Telefonie einiges getan: Die automatische Vermittlung, der Einsatz von Kompressionsverfahren, die Digitalisierung der Netze, usw. Doch auch heute noch ist die Entwicklung "Telefon" keinesfalls abgeschlossen. Gerade in den letzten Jahren...

Since the advent of hybridoma technology more than two decades ago, numerous antibodies have entered the clinical setting as potent therapeutic agents. Their repeated application in humans, however, is limited by the development of human antimouse antibodies (HAMA) in the recipient, leading to allergic re- tions against the foreign murine protein and rapid neutralization. To circumvent these limitations many new antibodies have recently been tailored through recombinant antibody technology. The initial clinical data show encouraging results, thus demonstrating the potential of these new...